Synergistic potential of botanicals as anti-inflammatory: A phyto pharmacognostical review

Inflammation​‍​‌‍​‍‌​‍​‌‍​‍‌ is a key defense mechanism of the body but its unregulated and long-term presence is the cause of many diseases. Along with them, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids as well, are very effective short-term relief agents but, on the other hand, associated with a broad spectrum of side effects, upon prolonged use. This circumstance has, among other things, opened the door for plant-based treatments as new promising approaches with fewer risks of undesirable effects. This review represents a systematic and comprehensive synthesis of evidence concerning the anti-inflammatory potential of the medicinal flora, with a major focus on their mechanistic basis and pharmacological validation. The article discusses the multiple-targeted mechanisms of the bioactive phytochemical components, among which impinging on the signal transduction pathways such as NF-κB, the enzymatic inhibition of Cyclooxygenase (COX) and Lipoxygenase (LOX), and the interactions with molecular targets like the NLRP3 inflammasome. A significant part of the paper is devoted to the quality control and efficacy testing methodologies. The research also made use of Thin-Layer Chromatography (TLC) in phytochemical profiling and standardizing the plant extracts. Besides, the review picks up the confirmation from the standard pharmacological studies assortment, including different in vitro bioassays and well-known in vivo animal models widely accepted in the anti-inflammatory and pain-relieving studies field. By the conjunction of in-depth mechanistic understanding with rigorous analytical and pharmacological evidence, this endeavor is designed to be a compelling scientific platform for the formulation of uniform, potent, and secure plant-based treatment regimens that target inflammation-related ‍​‌‍​‍‌​‍​‌‍​‍‌disorders.